|
⚲
|
| Keyboard |
| Lori Kunkel | |
|---|---|
| Firm | |
| Address | c/o Oric Pharmaceuticals, Inc 240 E Grand Avenue, 2nd Floor South San Francisco, CA 94080 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Oric Pharmaceuticals Inc | 021-548268 | Director | 125.0 M of 125.0 M |
||
| Oric Pharmaceuticals Inc | 021-503858 | Director | 125.0 M of 125.0 M |
||
| Oric Pharmaceuticals Inc | 021-485949 | Director | 85.0 M of 85.0 M |
||
| Nurix Therapeutics Inc | 021-363761 | Director | 120.2 M of 120.2 M |
||
| Maverick Therapeutics Inc | 021-278798 | Director | 56.0 M of 56.0 M |
||
| Tocagen Inc | 021-275725 | Director | 10.9 M of 13.0 M |
||
| Tocagen Inc | 021-197726 | Director | 46.2 M of 50.4 M |
||